il\VOLVEMENT OF RETII\OIC ACID II{ - MSpace at the University of ...

Minotti,G., P.Menna, E.Salvatorelli, G.Cairo, and L.Gianni '2004' "Anthracyclines:
molecular advances and pharmacologic developments in antitumor activity and
c ardiotoxic ity." P h arm a c o I - Rev. 5 6 :1 8 5 -229'
Minow,R.A. and J.A.Gottlieb. 197 5 . "Letter: Adriamycin cardiotoxicity. "
Ann. Intern. Med. 82 : 85 5 -85 6.
Misao,J., Y.Hayakawa, M.Ohno, S.Kato, T.Fujiwara, and H.Fujiwara. 1996' "Expression
of bcl-2 protein, an inhibitor of apoptosis, and Bax, an accelerator of apoptosis, in
ventricular myocytes of human hearts with myocardial infarction." Circulation.
94:1506-1512.
Miyashita,T., M.Harigai, M.Hanada, andJ.C.Reed' 1994' "Identification of a p53-
dependent negative response element in the bcl-2 gene." Cancer Res' 54:313I-
3 135.
Miyashita,T. and J.C.Reed. 1995. "Tumor suppressor p53 is a direct transcriptional
activator of the human bax gene." Cell' 80:293-299'
Moasser,M.M., R.J.Motzer,K.S.Khoo, P.Lyn, B.A.Murphy, G.J.Bosl, and E'Dmitrovsky'
1995. "all-trans retinoic acid for treating germ cell tumors. ln vitro activity and
results of a phase II trial." Cancer.76:680-686.
Molavi,B., H.Chen, and D.Li. Preservation of LV function following ischemiareperfusion
by the PPAR-gamma ligand rosiglitasone. Circulation 106(Suppl II),
168. 2005.
Ref Type: Generic
Moreno,P.R. and V.Fus ter. 2004. "New aspects in the pathogenesis of diabetic
atherothromb o sis. " J' Am' C o I l. C ar di o l. 4 4 :229 3 -23 00'
Moreno-M anzano,Y .,Y.Ishikawa, J.Lucio-C azana, and M.Kitamura. 1999 ' "Suppression
of apoptosis by all-trans-retinoic acid. Dual intervention in the c-Jun n-terminal
kinase-AP- 1 pathway. " J' B i ol. Ch em. 27 4:2025 | -20258'
t56